Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer (Q44799726)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer |
scientific article published in March 2004 |
Statements
1 reference
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer (English)
1 reference
Everett E Vokes
1 reference
Charles M Rudin
1 reference
Mark Kozloff
1 reference
Philip C Hoffman
1 reference
Martin J Edelman
1 reference
Robyn Karnauskas
1 reference
Ronald Tomek
1 reference
Livia Szeto
1 reference
1 March 2004
1 reference
1 reference
22
1 reference
6
1 reference
1110-1117
1 reference
Identifiers
1 reference
1 reference